VaramirStart free · no cardSign in
AUPH as of Oct 31 · 17:45 ET
AUPHNasdaqPharmaceutical Preparations

Aurinia Pharmaceuticals Inc. · Brief

Next report

117 days

Feb 25 · before openest.Q4 FY26
Earnings

Expected move

No implied move.

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±10.5%
avg realized
±4.6%
Feb 27 '25±14.7%▼−5.03%×0.34
May 12 '25±11.0%▲+1.50%×0.14
Jul 31 '25±8.9%▲+2.15%×0.24
Q3 FY25±12.8%▲+8.35%×0.65
Q1 FY26±10.8%▼−3.19%×0.30
May 7 '26±7.5%▼−6.80%×0.91
Q2 FY26±10.2%▲+6.19%×0.60
Q3 FY26±8.3%▼−3.25%×0.39
quarterimplied−15%0+15%realized×
Q3 FY26±8.3%▼−3.25%×0.39
Q2 FY26±10.2%▲+6.19%×0.60
May '26±7.5%▼−6.80%×0.91
Q1 FY26±10.8%▼−3.19%×0.30
Q3 FY25±12.8%▲+8.35%×0.65
Jul '25±8.9%▲+2.15%×0.24
2 older reports
May '25±11.0%▲+1.50%×0.14
Feb '25±14.7%▼−5.03%×0.34
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Feb 25 report · est.

—

Linked exposure

AUPH report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 29impliedImplied move: ±8.3% into Oct 30 earnings (Oct 29 close).Source
Oct 20impliedImplied move: ±8.9% into Nov 3 earnings (Oct 20 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.